J Mol Cell Cardio123,
1339-1342 (1991)
Can Altering R. Preston
Serum Maso~&~r*,
Cholesterol
Affect Neurologic
Leo G. Herbette1*2p3*4*5,
and David
See Also
Dr. Anna Mathew, MD - Lititz, PA - Family Medicine - Book AppointmentAll Care Therapies hiring Senior Customer Service Manager in Cerritos, CA | LinkedInVancouver Coastal Health hiring Physiotherapist 1 - Short Stay Unit in North Vancouver, British Columbia, Canada | LinkedInStudent Guide for Hospital Clinical Rotations - Blue Ridge EMS Council
Function? I. Sihrerman5
From the Departments of Radiology’, Biochemist$, the Centerfor Cardiovascular Membrane Research3, the Biomolecular Structure Analysis Center”, and the Cardiology Division of the Department of Medicine5, University of Connecticut Health Center, Fawnington, CT 06030, USA (Received 9 October 1990, accepted in revisedform 10 May 1991) Despite their success in establishing that cholesterol lowering reduces cardiovascular mortality, the major prospective primary prevention trials of the last decade have failed to produce a significant difference in overall mortality between both treatment and control groups [l-3].